Form 4: Disc Medicine Executive Pamela Stephenson Acquires 36,000 Shares of Common Stock and Stock Options

Pamela Stephenson, Chief Commercial Officer of Disc Medicine, Inc., reports the acquisition of 36,000 shares of common stock and stock options.

Summary

• Pamela Stephenson, Chief Commercial Officer of Disc Medicine, Inc., filed a Form 4 on February 12, 2025.
• The report details transactions from February 10, 2025, including the acquisition of 36,000 shares of common stock in the form of restricted stock units (RSUs) and stock options to purchase 36,000 shares.
• The RSUs vest in four annual installments starting February 15, 2026, contingent upon continued service.
• The stock options, with an exercise price of $54.71, vest in 48 equal monthly installments commencing on March 10, 2025, also subject to continued service.
• Following these transactions, Stephenson directly owns 72,666 shares of common stock and options for 36,000 shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard insider transaction report. The acquisition of shares and options by an executive could be interpreted as a slightly positive signal, but it's not definitively bullish.

Positives

• The acquisition of shares and options by a key executive could be seen as a positive sign, indicating confidence in the company's future prospects.

Future Outlook

The vesting schedules for both the RSUs and stock options are contingent upon the Reporting Person's continued service, suggesting an incentive for continued employment.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors for signals about management's view of the company's prospects.

Stakeholder Impact

• The transactions could have a minor positive impact on shareholder sentiment, as they reflect an executive's increased stake in the company.

Key Dates

Keywords

Form 4, insider trading, Pamela Stephenson, Disc Medicine, IRON, stock options, restricted stock units, RSUs, Chief Commercial Officer, beneficial ownership